John Hancock Multifactor Health Care ETF (JHMH) is an exchange-traded fund that focuses on the health care sector, utilizing a multifactor investment strategy to select stocks based on value, quality, and momentum. The fund's competitive position is bolstered by its diversified exposure to key health care sub-sectors, including pharmaceuticals, biotechnology, and medical devices, primarily in the U.S. market.
JHMH generates revenue primarily through management fees based on the total assets under management, which are calculated as a percentage of the fund's net asset value. The ETF's multifactor approach allows it to capitalize on various market conditions, providing a competitive edge by potentially outperforming traditional market-cap weighted indices.
Changes in health care policy and regulation impacting the sector
Performance of underlying health care stocks within the ETF
Market sentiment towards health care as a defensive sector during economic downturns
Interest rate changes affecting investor appetite for equities
Regulatory changes that could impact health care pricing and reimbursement
Technological disruption in health care delivery and pharmaceuticals
Increased competition from passive investment vehicles and other ETFs
Market volatility affecting investor confidence in health care investments
Potential liquidity risks if significant redemptions occur
Limited financial leverage as an ETF
moderate - The health care sector is generally considered defensive, but it can still be affected by overall economic conditions that influence consumer spending and investment.
Rising interest rates can lead to higher financing costs for health care companies, potentially impacting their profitability and stock performance, which in turn affects the ETF's value.
minimal
growth - Investors looking for exposure to health care growth opportunities through a multifactor approach.
moderate - The ETF's beta is expected to be moderate given its sector focus and diversified holdings.